M D Huband
Overview
Explore the profile of M D Huband including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfaller M, Huband M, Rhomberg P, Bien P, Castanheira M
Antimicrob Agents Chemother
. 2022 Oct;
66(11):e0102822.
PMID: 36286491
We evaluated the activity of manogepix and comparator agents against 1,435 contemporary fungal isolates collected worldwide from 73 medical centers in North America, Europe, the Asia-Pacific region, and Latin America...
2.
Pfaller M, Huband M, Flamm R, Bien P, Castanheira M
Antimicrob Agents Chemother
. 2019 Jun;
63(8).
PMID: 31182527
Current antifungal agents cover a majority of opportunistic fungal pathogens; however, breakthrough invasive fungal infections continue to occur and increasingly involve relatively uncommon yeasts and molds, which often exhibit decreased...
3.
Pfaller M, Rhomberg P, Huband M, Flamm R
Diagn Microbiol Infect Dis
. 2018 Mar;
91(2):179-183.
PMID: 29571839
Omadacycline is an aminomethylcycline with in vitro activity against many gram-negative pathogens. Omadacycline and comparators were tested against Enterobacteriaceae from urinary tract infections (UTIs) selected from a 2014 global surveillance...
4.
Pfaller M, Rhomberg P, Huband M, Flamm R
Diagn Microbiol Infect Dis
. 2017 Nov;
90(2):143-147.
PMID: 29157954
The activity of omadacycline and comparators when tested against a subset of Streptococcus pneumoniae from US and European regions of a 2014 global surveillance program (304 isolates) are reported. These...
5.
Cohen M, Huband M
Diagn Microbiol Infect Dis
. 1999 Feb;
33(1):43-6.
PMID: 9990475
Isolations of Staphylococcus aureus strains with reduced susceptibility to vancomycin are now being reported worldwide. In testing here by broth microdilution according to NCCLS guidelines and applying vancomycin breakpoint criteria...
6.
Cohen M, Huband M, Yoder S, Gage J, Roland G
J Antimicrob Chemother
. 1998 Aug;
41(6):605-14.
PMID: 9687098
Bactericidal activities of clinafloxacin, CI-990 and ciprofloxacin were examined and compared for a small collection of gram-positive and gram-negative pathogens. In-vitro antimicrobial activities were measured by MIC, MBC and time-kill...
7.
Cohen M, Huband M
J Antimicrob Chemother
. 1997 Aug;
40(2):308-9.
PMID: 9302005
No abstract available.
8.
Cohen M, Huband M, Gage J, Yoder S, Roland G, Gracheck S
J Antimicrob Chemother
. 1997 Aug;
40(2):205-11.
PMID: 9301985
Clinafloxacin and trovafloxacin are two new fluoroquinolones for which few comparative data are available. When MICs of ciprofloxacin against Gram-positive and Gram-negative nosocomial species were compared, clinafloxacin was the most...
9.
Sanchez J, Gogliotti R, Domagala J, Gracheck S, Huband M, Sesnie J, et al.
J Med Chem
. 1995 Oct;
38(22):4478-87.
PMID: 7473575
A series of 1-cyclopropyl-6-fluoro-8-alkoxy (8-methyoxy and 8-ethoxy)-quionoline-3-carboxylic acids and 1-cyclopropyl-5-amino-6-fluoro-8-alkoxyquinoline-3-carboxylic acids has been prepared and evaluated for antibacterial activity. In addition, they were also compared to quinolones with classic substitution...
10.
Cohen M, Gage J, Huband M, MESERVEY M, VanderRoest S, Yoder S
J Antimicrob Chemother
. 1995 Sep;
36(3):551-5.
PMID: 8830021
The new fluoroquinolones clinafloxacin, CI-990 (PD 131112/PD 131628), sparfloxacin, and PD 138312 were bactericidal against Staphylococcus aureus with MICs > or = 4-fold lower than ciprofloxacin values. In a murine...